Skip to content
Thomson Reuters
Corporate Governance

Chemed to pay $75 million over false claims lawsuit: Justice Dept

Reuters Staff

30 Oct 2017

WASHINGTON (Reuters) – Chemed Corp and subsidiaries including Vitas Hospice Services LLC and Vitas Healthcare Corp have agreed to pay $75 million to resolve a federal lawsuit alleging false claims for hospice services to Medicare, the U.S. Justice Department said on Monday.

The allegations relate to billing for ineligible patients and inflated levels of care, the department said in a statement. Vitas Hospice Services is the largest U.S. for-profit hospice chain, it said.

Reporting by Eric Walsh; Editing by Mohammad Zargham
Our Standards:The Thomson Reuters Trust Principles.
Uber’s messy data breach collides with launch of SoftBank deal Nissan cites staff shortage for improper tests, plans more inspectors Tesla says it will fight lawsuit claiming racial discrimination Wells Fargo repays $5.4 million for repossessing service members’ cars Peak oil? Majors aren’t buying into the threat from renewables HSBC pledges $100 billion of finance by 2025 to combat climate change No joke: China’s war on pollution roils world’s top pig farming sector Turkey’s Global Yatirim eyes green energy deals after London investment Study predicts slow, steady rise of electric vehicles to 2030 Audi recalls 5,000 diesel cars to fix emissions control software